03Jul
Committed to Clarity: FDA’s Dedication to Transparency with the End of ASR
On June 21, the Food and Drug Administration (FDA) released a report titled “Statement on agency’s efforts to increase transparency in medical device reporting.” This report describes updates to FDA’s Medical Device Reporting (MDR) Program, namely...
By:
Morrison & Foerster LLP
Related
Happy 2020! Welcome to the first edition of Policy Matters in this Presidential election year! Under...
Read More >
In our ever-increasing multi-multinational workforce that seems to rely more heavily on foreign labo...
Read More >
After a slightly inauspicious start, involving the rejection by the European Parliament of three can...
Read More >
As we began to describe on March 18, the economic impacts of the ongoing coronavirus/COVID-19 pandem...
Read More >
On December 12, 2019, the California Court of Appeal for the First Appellate District handed down a ...
Read More >
COVID-19, also known as the novel coronavirus, has spread rapidly throughout the globe since it firs...
Read More >